Wockhardt (WOCKPHARMA) Share Price Fall Streak Extends for Second Straight Session

Wockhardt Share Price Fall Streak is in focus as the stock traded lower in its second straight session, with the latest traded price at Rs 1,922 and a cumulative fall of 3.77% across the run from Rs 1,997.2. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established. The move keeps Wockhardt Share Price Fall Streak on the radar because the decline is now larger than a one-session dip and has persisted across two lower sessions.

Wockhardt Share Price Fall Streak also matters because the company’s market capitalisation stands at Rs 32,452.94 crore, placing it in the Large Cap bracket for context. For readers tracking Wockhardt Share Price Today, the key point is not only the percentage change but the fact that consecutive lower sessions change how the market reads the move versus a single-day decline. The latest run keeps Wockhardt Share Price Fall Streak tied to price action, valuation context and sector comparison rather than to any stated trigger.

Wockhardt (WOCKPHARMA) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 1,922
Previous Close	Rs 1,964.3
Today's Move	-Rs 42.30 (-2.15%)
Open	Rs 1,970
High	Rs 1,971.4
Low	Rs 1,920.15
Market Capitalisation	Rs 32,452.94 crore

Wockhardt Share Price Fall Streak opened the session at Rs 1,970, touched a high of Rs 1,971.4 and a low of Rs 1,920.15, and was last traded at Rs 1,922. Versus the previous close of Rs 1,964.3, the stock was down Rs 42.3, or 2.15%, at the latest reading. The day’s range shows that the stock stayed near the lower end of the session after the opening level, with the latest price sitting just above the intraday low. Wockhardt Share Price Fall Streak therefore reflects a lower intraday footing rather than a recovery back toward the day’s upper band.

Market capitalisation at Rs 32,452.94 crore places Wockhardt Share Price Fall Streak in the Large Cap category for this article. That scale matters for Wockhardt Share Price Today because a second straight lower session is being read against a large market value rather than a smaller base. The headline price fall is modest in rupee terms, but the two-session pattern makes Wockhardt Share Price Fall Streak more relevant for readers following stock news, price action and the broader market update on the name. The next read-through comes from fundamentals and valuation context.

What the Consecutive Declines Show

Wockhardt Share Price Fall Streak now reflects a second straight session of decline, with the cumulative move since Rs 1,997.2 standing at 3.77%. That cumulative figure is the key difference from a single-day fall: the latest price is not just lower versus the previous close, it is also lower across a two-session sequence. For readers of Wockhardt Share Price Fall Streak, the important detail is the pattern itself, because repeated lower sessions change the context around Wockhardt Share Price Today even when no company-specific reason is established.

According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the streak a data-led event rather than a narrative-led one. Wockhardt Share Price Fall Streak therefore remains a clean market update: the stock has moved lower twice in a row, the latest traded price is below both the previous close and the start of the streak, and the arithmetic confirms a sustained downside sequence rather than a one-off swing. The valuation lens becomes more important when the decline is viewed alongside the company’s earnings base and book value.

Wockhardt (WOCKPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 32,452.94 crore
P/E Ratio	78.04x
P/B Ratio	6.34x
ROE	4.29%
ROCE	6.79%
EPS	Rs 25.17
Book Value Per Share	Rs 309.81
Dividend Yield	0%

Wockhardt (WOCKPHARMA) fundamental metrics show P/E 78.04x, P/B 6.34x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.

Wockhardt has a market capitalisation of Rs 32,452.94 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 78.04x, P/B at 6.34x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	78.04x
Benchmark Median P/E	31.63x
Benchmark Average P/E	47.13x
Benchmark P/E Range	3.21x to 676.52x
Company P/B Ratio	6.34x
Benchmark Median P/B	2.86x
Benchmark Average P/B	4.25x
Company ROE	4.29%
Benchmark Median ROE	11.61%
Benchmark Average ROE	10.59%
Company ROCE	6.79%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.35%
Company Market Capitalisation	Rs 32,452.94 crore
Benchmark Median Market Cap	Rs 814.52 crore
Benchmark Average Market Cap	Rs 13,724.94 crore

Wockhardt (WOCKPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Wockhardt (WOCKPHARMA) has a P/E ratio of 78.04x, which is above the benchmark median of 31.63x, a difference of +146.73%. On its own, the P/E gap is a valuation reference point, not a trading call.

Wockhardt (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.61%, a difference of -63.05%. Wockhardt (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.46%, a difference of -49.55%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,21,539.16	34.89	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,47,576	85.12	14.1	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,77,251.42	81.6	19.83	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,11,231.65	25.18	4.21	19.69	21.39
Laurus Labs	LAURUSLABS	1,09,796.85	102.34	19.84	18.31	18.2

Wockhardt (WOCKPHARMA) has a P/E ratio of 78.04x compared with the displayed peer median of 81.6x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 4.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt (WOCKPHARMA) has a market capitalisation of Rs 32,452.94 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Wockhardt

• Wockhardt Share Price Fall Streak is now in its second straight session, making the move more than a one-day fluctuation.
• The latest traded price of Rs 1,922 is below the previous close of Rs 1,964.3 and below the streak start base of Rs 1,997.2.
• P/E at 78.04 and P/B at 6.34 keep Wockhardt Share Price Fall Streak at premium valuation levels versus the same-industry benchmark.
• ROE of 4.29% and ROCE of 6.79% remain below the benchmark medians, which keeps the fundamentals in focus.
• Market capitalisation of Rs 32,452.94 crore places Wockhardt Share Price Fall Streak in the Large Cap category for context.

About Wockhardt

Wockhardt operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For Wockhardt Share Price Fall Streak, the business context matters because the stock is being assessed against an industry that typically trades on earnings visibility, return ratios and valuation discipline. The company’s current market cap, earnings multiples and book-value base are the main reference points available here, so the streak is best understood through those numbers rather than through a broader corporate narrative. Wockhardt Share Price Today therefore stays linked to how investors compare its valuation and returns with other pharmaceutical names in the same industry.

Track Wockhardt Share Price on Univest

Use Wockhardt (WOCKPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track Wockhardt Share Price Fall Streak on Univest for live share price updates, key fundamental ratios, 52-week levels and market insights in one place. Wockhardt Share Price Today can be followed alongside valuation metrics, sector comparison and company-level context. Univest keeps the price action, fundamentals and industry frame together for quicker reading.

Frequently Asked Questions

Why is Wockhardt Share Price Fall Streak in focus today?

Ans. Wockhardt Share Price Fall Streak is in focus because it has registered a second straight lower session. The latest traded price was Rs 1,922, down 2.15% from the previous close of Rs 1,964.3.

What is the latest price in Wockhardt Share Price Fall Streak?

Ans. The latest traded price in Wockhardt Share Price Fall Streak is Rs 1,922. It moved within an intraday range of Rs 1,920.15 to Rs 1,971.4 after opening at Rs 1,970.

How much has Wockhardt Share Price Fall Streak fallen across the run?

Ans. Across the second straight session, Wockhardt Share Price Fall Streak has fallen 3.77% from the streak start base price of Rs 1,997.2. That cumulative move is the main difference from a single-day decline.

What does Wockhardt Share Price Fall Streak show about valuation?

Ans. Wockhardt Share Price Fall Streak still trades at a P/E of 78.04 and a P/B of 6.34. Those levels remain above the same-industry benchmark median, even after the two-session decline.

How do Wockhardt Share Price Fall Streak returns compare with the industry?

Ans. Wockhardt Share Price Fall Streak shows ROE of 4.29% and ROCE of 6.79%, both below the same-industry benchmark medians. That keeps return ratios weaker than the industry midpoint. The previous close was Rs 1,964.3.

What is Wockhardt Share Price Fall Streak market capitalisation?

Ans. Wockhardt Share Price Fall Streak has a market capitalisation of Rs 32,452.94 crore. the category is Large Cap, and that scale places it above the benchmark market-cap median.

How does Wockhardt compare with peers on P/E and P/B?

Ans. Wockhardt Share Price Fall Streak is above Zydus Lifesciences, Cipla, Dr. Reddy’s Laboratories and Sun Pharma on P/E and P/B, while Laurus Labs is higher on both multiples among the listed peers.

Does Wockhardt Share Price Fall Streak pay a dividend?

Ans. the dividend yield for Wockhardt Share Price Fall Streak is 0. That means the current price move is not accompanied by a dividend yield contribution in the data shown.

What should investors monitor in Wockhardt Share Price Fall Streak next?

Ans. Investors tracking Wockhardt Share Price Fall Streak can monitor whether the stock holds above the intraday low, how the valuation compares with peers, and whether the second straight decline extends into another session.